↑ トップへ　← 戻る

 Drug（薬物リスト） ALL | DrugBank 

   e.g. "Sirolimus", "アダリムマブ"    Synonyms (Drugs) were also searched for.

A　B　C　D　E　F　G　H　 I 　J　K　L　M　N　O　P　Q　R　S　T　U　V　W　X　Y　Z　other

306 / 1,666 drugs found* Show info (disease name, etc.) on mouse-over.
 No.   DrugBank   薬物名（臨床試験情報から抽出）   KEGG DRUG *   KEGG GENES *   KEGG PATHWAY   指定難病告示番号 * 
 1   ATL1102  1件: Atl1102;   -   -   -   1件:
13
 2   Abatacept  27件: Abatacept; Abatacept injection; Bms 188667 (abatacept); Abatacept (aba) + methotrexate (mtx), double-blind (db); Abatacept (bms-188667); Abatacept (iv); Abatacept + csdmard; Abatacept + methotrexate; Abatacept + vaccines; Abatacept placebo; Abatacept prefilled syringe; Abatacept, rituximab or tocilizumab; Bdmard withdrawal (etanercept, adalimumab, infliximab, certolizumab, golimumab, tozilizumab, abatacept); Decrease tocilizumab, abatacept; Double-blind abatacept; Intravenous (iv) abatacept; Iv abatacept; Open-label abatacept; Orencia (abatacept); Orencia abatacept; Subcutaneous (sc) abatacept; Subcutaneous abatacept; Subcutaneous(sc) abatacept; Tocilizumab, abatacept; Abatacept subcutaneous; Abatacept sc; Abatacept (aba);   D03203   2件: CD80, CD86   3件: Cell adhesion molecules (CAMs), Intestinal immune network for IgA production, Rheumatoid arthritis   24件:
11,
13,
19,
41,
44,
46,
49,
50,
51,
53,
55,
60,
65,
84,
93,
96,
97,
107,
164,
222,
271,
284,
285,
300
 3   Acetaminophen  8件: Acetaminophen; Acetaminophen tab 650mg; Acetaminophen/paracetamol; Acetaminophen tablets; Paracetamol (acetaminophen); Tramadol hydrochloride + acetaminophen; Oxycodone/acetaminophen; Tramadol /acetaminophen;   D00217   2件: PTGS1, PTGS2   1件: Arachidonic acid metabolism   13件:
3,
6,
13,
34,
35,
46,
49,
51,
70,
86,
231,
256,
271
 4   Acetate  81件: Acetate; Leuprorelin acetate; 40 mg glatiramer acetate; Betamethasone sodium phosphate/betamethasone acetate (celestone® soluspan®), 30 mg im once a day for four days; Flecainide acetate; Oxaloacetate (oaa); Ulipristal acetate; 11c-acetate; 20mg/0.5ml glatiramer acetate; Bazedoxifene acetate; Cyclophosphamide/glatiramer acetate; Dirucotide acetate; Experimental glatiramer acetate; Glatiramer acetate; Glatiramer acetate (db); Glatiramer acetate (ga); Glatiramer acetate (ga) 40 mg; Glatiramer acetate (ol); Glatiramer acetate 150mg enteric coated tablets; Glatiramer acetate 150mg enteric-coated (gastro-resistant) tablets; Glatiramer acetate 20 mg; Glatiramer acetate 20 mg, with mitoxantrone; Glatiramer acetate 20 mg/0.5 ml; Glatiramer acetate 40 mg; Glatiramer acetate injection with oral cetirizine hydrochloride; Glatiramer acetate with minocycline; Glatiramer acetate, (copaxone®); Glatiramer acetate, ifn-beta 1a (im), ifn-beta 1a (subcutaneous), and ifn-beta 1b; Glatiramer acetate, n-acetylcysteine; Human interferon beta-1a and glatiramer acetate; Nomegestrol acetate; Plovamer acetate; Prednisone acetate; Loestrin 1.5/30 (1.5 mg norethindrone acetate/30 µg ethinyl estradiol); Sodium-[o-[(2,6-dichlorophenyl)-amino]-phenyl]-acetate; Tocopherol acetate; Depot leuprolide acetate 3.75 mg; Caspofungin acetate; Desmopressin acetate; Lanreotide acetate; Abiraterone acetate; Gonadorelin acetate and triptorelin acetate; Leuprolide acetate (la); Leuprolide acetate 11.25 mg; Leuprolide acetate 3 month depot; Leuprolide acetate 30 mg; Leuprolide acetate 45 mg; Leuprolide acetate depot; Leuprorelin acetate 3.75mg injection; Luphere depot 3.75mg(leuprolide acetate 3.75mg); Lupron (leuprolide acetate); Megestrol acetate; Megestrol acetate tablet; Triptorelin acetate and gonadorelin acetate; Macimorelin acetate; Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone); Cortisone acetate; Hydrocortisone sodium acetate; Sodium acetate; Tetracosactide acetate; 11c acetate; Dichloroacetate; Dichloroacetate sodium; Zuretinol acetate; Etiprednol dicloacetate; Delmitide acetate; L-lysyl-d-prolyl-l-threonine acetate; Sotrastaurin (inn) acetate; Cosyntropin acetate; Tetracosactide hexaacetate; Glatiramer acetate (copaxone®); Zinc acetate; Zinc acetate dihydrate; Tocopheryl acetate; Prednisolone acetate; Prednisone acetate tablets; Desmopressin acetate trihydrate; Phosphate and betamethasone acetate, 2 ml.; [n-trans-3-hexenoyl] human growth hormone releasing factor (1-44) acetate; Loestrin (norethindrone acetate and ethinyl estradiol); Zinc acetate (20mg/d);   -   -   -   40件:
1,
2,
6,
10,
13,
35,
40,
46,
49,
51,
60,
64,
70,
71,
73,
75,
76,
78,
81,
83,
85,
86,
88,
90,
96,
97,
113,
145,
156,
162,
171,
206,
222,
224,
225,
235,
265,
288,
298,
299
 5   Acetazolamide  2件: Acetazolamide; Acetazolamide sandoz 250;   D00218
 D01196 		  2件: CA2, CA4   1件: Proximal tubule bicarbonate reclamation   6件:
13,
90,
115,
155,
225,
230
 6   Acetic acid C-11  0件:   -   -   -   3件:
13,
86,
88
 7   Acetylcysteine  8件: Acetylcysteine; N-acetylcysteine; N-acetylcysteine capsule; Glatiramer acetate, n-acetylcysteine; N acetylcysteine; N-acetylcysteine (nac); N-acetylcysteine, (nac); Acetylcysteine sodium;   D00221   -   -   16件:
6,
13,
19,
20,
49,
51,
58,
85,
94,
96,
97,
111,
164,
233,
298,
299
 8   Acetylsalicylic acid  2件: Acetylsalicylic acid; Acetylsalicylic acid at 1st visit,;   D00109   2件: PTGS1, PTGS2   1件: Arachidonic acid metabolism   10件:
13,
22,
34,
46,
49,
51,
86,
113,
158,
231
 9   Activated charcoal  0件:   D03251   -   -   8件:
6,
13,
46,
85,
86,
96,
97,
298
 10   Acyclovir  1件: Acyclovir;   D00222   -   -   5件:
13,
28,
46,
53,
60
 11   Adenosine  6件: 2-cda, 2-chloro-2’-deoxy-beta-d-adenosine; 2-cda, 2-chloro-2’-deoxy-ß-d-adenosine; 2-chloro-2'-deoxyadenosine, 2cda; 2-chloro-2’-deoxyadenosine (2-cda); Adenosine; Autologous ex vivo gene therapy products based on the efs lv encoding for the human adenosine deaminase (ada) gene (efs-ada lv);   D00045   4件: ADORA1, ADORA2A, ADORA2B, ADORA3   2件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction   5件:
13,
46,
53,
58,
65
 12   Alemtuzumab  18件: Alemtuzumab; Alemtuzumab (gz402673); Alemtuzumab 12 mg; Alemtuzumab 24 mg; Alemtuzumab gz402673; Alemtuzumab immunotherapy; Alemtuzumab injection [lemtrada]; Alemtuzumab (campath); Alemtuzumab (already received by alemtuzumab cohort between 1991 and 1994; Alemtuzumab (already received by alemtuzumab cohort between 1991 and 1994); Alemtuzumab (campath ); Alemtuzumab and rituximab; Alemtuzumab, rituximab; Alemtuzumab 0.2 mg; Alemtuzumab 0.3 mg; Filgrastim, alemtuzumab; Transplant conditioning with mobilization and alemtuzumab; Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan;   D02802   -   -   17件:
13,
15,
19,
20,
46,
49,
51,
60,
63,
65,
85,
96,
164,
234,
284,
285,
326
 13   Alfuzosin  1件: Alfuzosin;   D01692
 D07124 		  1件: ADRA1A   3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   1件:
13
 14   Amantadine  10件: 240mg amantadine hcl er tablets; 320mg amantadine hcl er tablets; Ads-5102 (extended release amantadine hcl); Amantadine; Amantadine 300 mg; Amantadine hcl er; Amantadine hcl extended release; Amantadine hydrochloride; Amantadine sulfate; Pk-merz® 200mg/500ml inj(amantadine) , normal saline 500ml inj;   D00777
 D07441 		  5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   3件: Dopaminergic synapse, Glutamatergic synapse, Neuroactive ligand-receptor interaction   4件:
6,
8,
13,
127
 15   Amiloride  6件: Amiloride; Amiloride hydrochloride; Amiloride hydrochloride, 2 h2o; Hydrochlorothiazide/amiloride; Amiloride hcl; Amiloride solution for inhalation;   D00649
 D07447 		  3件: SCNN1A, SCNN1B, SCNN1G   1件: Aldosterone-regulated sodium reabsorption   3件:
13,
225,
299
 16   Anakinra  8件: Anakinra; Anakinra (kineret®); Anakinra (r-methuil-1ra); Anakinra and peg stnf-r1; Kineret® (anakinra); Response to anakinra associated with methotrexate; Anakinra / kineret; Kineret® or anakinra;   D02934   2件: IL1R1, IL1R2   2件: Cytokine-cytokine receptor interaction, Inflammatory mediator regulation of TRP channels   17件:
2,
13,
15,
19,
37,
41,
46,
49,
50,
56,
65,
84,
86,
106,
107,
266,
299
 17   Arbaclofen  7件: Arbaclofen; Arbaclofen er tablets; Arbaclofen extended release tablets; Arbaclofen placarbil; Arbaclofen placarbil 15 mg bid; Arbaclofen placarbil 30 mg bid; Arbaclofen placarbil 45 mg bid;   D09791   2件: GABBR1, GABBR2   3件: GABAergic synapse, Neuroactive ligand-receptor interaction, cAMP signaling pathway   2件:
13,
206
 18   Arbaclofen Placarbil  4件: Arbaclofen placarbil; Arbaclofen placarbil 15 mg bid; Arbaclofen placarbil 30 mg bid; Arbaclofen placarbil 45 mg bid;   D08861   2件: GABBR1, GABBR2   3件: GABAergic synapse, Neuroactive ligand-receptor interaction, cAMP signaling pathway   1件:
13
 19   Armodafinil  1件: Armodafinil;   D03215   1件: SLC6A3   1件: Dopaminergic synapse   3件:
6,
13,
84
 20   Ascorbic acid  4件: Ascorbic acid; Ascorbic acid (vitamin c); Ascorbic acid vit c; 2l polyethylene glycol/ascorbic acid;   D00018   -   -   13件:
10,
13,
49,
62,
86,
96,
97,
192,
206,
211,
212,
254,
284
 21   Aspartic acid  0件:   D00013   -   -   3件:
13,
75,
299
 22   Atacicept  8件: Atacicept; Atacicept 150 mg; Atacicept 25 mg; Atacicept 75 mg; Atacicept 75 milligram (mg); Atacicept150mg; Atacicept25mg; Atacicept75mg;   D09704   2件: TNFSF13, TNFSF13B   2件: Cytokine-cytokine receptor interaction, Rheumatoid arthritis   4件:
13,
46,
49,
66
 23   Atomoxetine  1件: Atomoxetine;   D02574
 D07473 		  1件: SLC6A2   1件: Synaptic vesicle cycle   3件:
6,
8,
13
 24   Atorvastatin  9件: Atorvastatin; Interferon beta treatment to add-on atorvastatin treatment; Interferon beta-1b/atorvastatin group; Untreated to atorvastatin treatment; Atorvastatin tablet 20 mg; Atorvastatin 10mg; Atorvastatin 20mg; Lisinopril, losartan, and atorvastatin; Atorvastatin calcium;   D00258
 D00887
 D07474 		  1件: HMGCR   1件: Terpenoid backbone biosynthesis   17件:
13,
46,
49,
51,
58,
63,
79,
84,
88,
93,
96,
160,
222,
225,
265,
271,
299
 25   Azathioprine  33件: Azathioprine; Prednisone - azathioprine; Azathioprine (aza); Combination of protein a immunoadsorption, rituximab, dexamethasone plus azathioprine; Corticosteroid and azathioprine; Cyclophosphamide, azathioprine,prednisone,methylprednisolone; Azathioprine 25 mg; Continuation of azathioprine; Cyclophosphamide-prednisone-azathioprine; Immunosuppressive regime (azathioprine, mycophenolate mofetil or methotrexate); Rituximab (rtx) and azathioprine (aza); Steroids plus azathioprine; Azathioprine/prednisone; 5-asa, prednisone, azathioprine or remicade; Azathioprine (aza) or 6-mercaptopurine (6-mp); Azathioprine in case of endoscopic recurrence; Azathioprine individualised dose; Azathioprine or 6-mercaptopurine; Azathioprine or adalimumab and infliximab; Azathioprine or mesalazine; Azathioprine or methotrexate; Azathioprine weight-based dose; Azathioprine+enteral nutrition; Early immunosuppressants (azathioprine, methotrexate); Infliximab and azathioprine combination at week 0; Infliximab and azathioprine combination at week 14; Infliximab with azathioprine (iifx + aza); Infliximab+azathioprine; Infliximab, azathioprine; Azathioprine and allopurinol; Overencapsulated azathioprine (imuran) 50 mg tablet; Products containing azathioprine or 6-mercaptopurine; Azathioprine or mycophenolate mofetil;   D00238
 D03033 		  -   -   18件:
11,
13,
19,
35,
42,
43,
44,
45,
46,
49,
65,
66,
85,
94,
95,
96,
97,
162
 26   Azithromycin  12件: Azithromycin; Azithromycin 250mg capsule; Azithromycin + metronidazole; Azithromycin (zitromax°); Azithromycin + n-acetylcystein + inhaled corticosteroid; Azithromycin dihydrate; Azithromycine; Azithromycine 250 mg; Azithromycin 250 mg tablets; Azithromycin 500 mg film-coated tablet; Po azithromycin; Study medication, azithromycin;   D02134
 D06390
 D07486 		  -   -   6件:
13,
84,
85,
96,
228,
299
 27   Baclofen  12件: Baclofen; Rs-baclofen; Aert, (r)-baclofen; Arbaclofen; Arbaclofen er tablets; Arbaclofen extended release tablets; Arbaclofen placarbil; Arbaclofen placarbil 15 mg bid; Arbaclofen placarbil 30 mg bid; Arbaclofen placarbil 45 mg bid; Baclofen 20 mg; Baclofen ir;   D00241   2件: GABBR1, GABBR2   3件: GABAergic synapse, Neuroactive ligand-receptor interaction, cAMP signaling pathway   5件:
2,
10,
13,
18,
149
 28   Baminercept  3件: Baminercept; Baminercept alfa; Baminercept alfa (bg9924);   D08866   1件: LTB   3件: Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Rheumatoid arthritis   4件:
13,
46,
53,
97
 29   Bazedoxifene  2件: Bazedoxifene; Bazedoxifene acetate;   D03062   -   -   1件:
13
 30   Beta carotene  2件: Beta carotene; Beta carotene from dunaliella algae;   D03101   -   -   2件:
13,
96
 31   Beta-Alanine  2件: Beta-alanine; Beta-alanine supplementation;   D07561   -   -   1件:
13
 32   Bevacizumab  4件: Bevacizumab; Bevacizumab (genitical recombination); Bevacizumab (avastin) and imatinib mesylate (gleevec); Submucosal bevacizumab;   D06409   1件: VEGFA   3件: Pathways in cancer, Renal cell carcinoma, VEGF signaling pathway   9件:
13,
34,
85,
86,
87,
89,
227,
280,
331
 33   Bexarotene  1件: Bexarotene;   D03106   3件: RXRA, RXRB, RXRG   3件: Adipocytokine signaling pathway, PPAR signaling pathway, Pathways in cancer   2件:
13,
75
 34   Biotin  3件: Biotin; D-biotin; Prebiotics (prebiotin prebiotic fiber stick pac);   D00029   -   -   3件:
2,
13,
20
 35   Bisacodyl  1件: Bisacodyl;   D00245   -   -   1件:
13
 36   Borage oil  2件: Borage oil; Borage oil 20% gla;   -   -   -   1件:
13
 37   Bosentan  14件: Bosentan; Bosentan mylan; Bosentan (tracleer); Bosentan 125 mg; Bosentan 62.5 mg; Bosentan group; Bosentan monohydrate; Sildenafil 20mg and bosentan 62.5mg; Bosentan administration; Bosentan and sildenafil; Bosentan monohydrat; Bosentan, ambrisentan; Era and pde-5i (sildenafil, tadalafil, bosentan, macitentan); Sildenafil singly or in association with bosentan;   D01227
 D07538 		  2件: EDNRA, EDNRB   2件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction   10件:
13,
41,
47,
51,
84,
85,
86,
88,
210,
211
 38   Botulinum toxin type A  3件: Botulinum toxin type a; Clostridium botulinum toxin type a; Botulinum toxin type a (nabota®) injection into the gastrocnemius muscle;   D00783   1件: SNAP25   1件: Synaptic vesicle cycle   13件:
2,
5,
6,
7,
13,
15,
17,
36,
51,
70,
113,
149,
226
 39   CDP323  1件: Cdp323;   -   -   -   1件:
13
 40   Calcium  26件: Calcium; Calcium carbonate; Calcium levofolinate; Ascal(r) / carbasalate calcium; Calcium and cholecalciferol; Calcium citrate; Carbasalate calcium; Ethylhydrogenfumarat, calciumsalz; Ibandronate+alfacalcidol+calcium; Rosuvastatin calcium; Calcium channel blockers; Calcium channel blockers (amlodipine, azelnidipine); Calcium rosuvastatin; Crestor tablets (calcium rosuvastatin) film-coated tablets; Calcium citrate with vitamin d2; Vidofludimus calcium; Calcium gluconate; Symptomatic treatment (converting enzyme inhibitor, angiotensin ii, anti-renin, aldosterone antagonist diuretic, beta blocker, calcium inhibitor, statin); Low molecular weight heparin calcium injection; Amorphous calcium carbonate; Calcitriol & calcium; Calcium carbonate and alphacalcidol; Calcium lactate; Crystalline calcium supplements; Atorvastatin calcium; Calcium, dietary;   -   -   -   24件:
6,
13,
19,
46,
49,
51,
65,
68,
75,
79,
84,
93,
94,
95,
96,
97,
214,
215,
222,
224,
235,
265,
298,
299
 41   Calcium Carbonate  3件: Calcium carbonate; Amorphous calcium carbonate; Calcium carbonate and alphacalcidol;   D00932
 D10802 		  -   -   7件:
13,
19,
46,
75,
96,
235,
299
 42   Cannabidiol  6件: Cannabidiol; Cannabidiol / dronabinol capsule 5 mg+2,5 mg; Cannabidiol capsule 5 mg; Cannabidiol tablet 10 mg; Cannabidiol (cbd); Cannabidiol oral solution;   D10915   2件: CNR1, CNR2   1件: Neuroactive ligand-receptor interaction   14件:
2,
6,
13,
46,
95,
96,
97,
140,
144,
145,
157,
158,
193,
271
 43   Carbidopa  60件: Carbidopa; Carbidopa-levodopa; Accordion pill carbidopa/levodopa; Accordion pill™ carbidopa/levodopa; Accordion pill™ carbidopa/levodopa 50/400 mg; Accordion pill™ carbidopa/levodopa 50/500 mg; Capsules containing: carbidopa (25 mg), levodopa (100 mg), entacapone (200 mg); Carbidopa 20 mg; Carbidopa 27.5 mg; Carbidopa 65 mg capsule; Carbidopa and levodopa 25mg/100mg; Carbidopa fu; Carbidopa levodopa; Carbidopa monohydrate; Carbidopa, levodopa, entacapone; Carbidopa- levodopa; Carbidopa/l-dopa; Carbidopa/l-dopa/entacapone; Carbidopa/levodopa; Carbidopa/levodopa, immediate release; Carbidopa/levodopa/entacapone; Comparator: carbidopa; Continuous intrajejunal infusion of levodopa-carbidopa; Controlled-release levodopa / carbidopa; Entacapone and carbidopa; Immediate release carbidopa/levodopa; Immediate release carbidopa/levodopa 25/100 mg; Levodopa and carbidopa; Levodopa and carbidopa sc solution; Levodopa and carbidopa solution for sc administration; Levodopa carbidopa (lc) oral encapsulated immediate release (ir) tablets; Levodopa carbidopa intestinal gel (lcig); Levodopa, carbidopa, entacapone; Levodopa, carbidopa, odm-104; Levodopa-carbidopa; Levodopa-carbidopa (lc) oral encapsulated immediate release (ir) tablets; Levodopa-carbidopa immediate release (lc-ir) tablets; Levodopa-carbidopa intestinal gel; Levodopa-carbidopa multilayer extended release tablet; Levodopa-carbidopa xl tablet (m); Levodopa-carbidopa-entacapone; Levodopa/carbidopa; Levodopa/carbidopa (sinemet); Levodopa/carbidopa 100/25; Levodopa/carbidopa hydrate; Levodopa/carbidopa solution; Levodopa/carbidopa(200mg/50mg); Levodopa/carbidopa/entacapone; Nd0612 (levodopa/carbidopa solution); Odm-101 105mg carbidopa; Odm-101 65mg carbidopa; Oral levodopa and carbidopa; Oral levodopa/carbidopa; Sinemet (levodopa/carbidopa); Sinemet plus (levodopa/carbidopa); Sinemet® controlled release (carbidopa/levodopa); Stalevo (levodopa/ carbidopa/ entacapone); Stalevo (levodopa/carbidopa/entacapona); Xp21279 and carbidopa (experimental); Levodopa/carbidopa (4:1);   D00558   1件: DDC   2件: Dopaminergic synapse, Serotonergic synapse   8件:
2,
4,
6,
13,
17,
90,
164,
201
 44   Carbonate ion  0件:   -   -   -   10件:
2,
13,
17,
19,
46,
75,
96,
127,
235,
299
 45   Carmustine  2件: Carmustine; Carmustine, etoposide, cytarabine, and melphalan (beam);   D00254   -   -   5件:
11,
13,
14,
28,
60
 46   Carnosine  3件: Carnosine; Carnosine supplementation; Carnosine, capsulle, 2 g/day, 8 weeks;   -   -   -   2件:
6,
13
 47   Cetirizine  4件: Cetirizine; Cetirizine hydrochloride; Glatiramer acetate injection with oral cetirizine hydrochloride; Antihistamine (cetirizine or equivalent);   D00664
 D07662 		  1件: HRH1   2件: Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction   2件:
13,
35
 48   Chloride ion  0件:   -   -   -   17件:
6,
11,
13,
14,
34,
46,
51,
96,
97,
127,
168,
193,
227,
228,
288,
297,
299
 49   Chloroxylenol  0件:   D03473   -   -   4件:
6,
13,
46,
168
 50   Cholecalciferol  9件: Cholecalciferol; Cholecalciferol, vitamin d3; Calcium and cholecalciferol; Cholecalciferol and c. xanthorrhiza; Cholecalciferol 10,000 iu; Cholecalciferol 400 iu; Cholecalciferol concentrate; 5000 iu of cholecalciferol; Cholecalciferol (vitamin d3);   D00188   1件: VDR   2件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption   15件:
6,
13,
19,
20,
34,
46,
49,
53,
60,
65,
96,
97,
228,
298,
299
 51   Cholestyramine  1件: Cholestyramine;   -   -   -   5件:
13,
79,
93,
254,
297
 52   Cisapride  1件: Cisapride;   D00274
 D02092 		  3件: HTR2A, HTR3A, HTR4   3件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse   1件:
13
 53   Cladribine  4件: Cladribine; Cladribine 3.5 mg/kg; Cladribine 5.25 mg/kg; Cladribine tablets;   D01370   1件: RRM1   2件: Purine metabolism, Pyrimidine metabolism   2件:
13,
94
 54   Clemastine  1件: Clemastine;   D00666
 D03535 		  1件: HRH1   2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction   1件:
13
 55   Clostridium botulinum  2件: Clostridium botulinum; Clostridium botulinum toxin type a;   -   -   -   1件:
13
 56   Coconut  3件: Coconut; Coconut oil; Coconut oil and epigallocatechin gallate;   -   -   -   1件:
13
 57   Coconut oil  2件: Coconut oil; Coconut oil and epigallocatechin gallate;   D05326   -   -   1件:
13
 58   Coenzyme M  0件:   -   -   -   9件:
13,
44,
45,
49,
51,
60,
65,
96,
164
 59   Corticotropin  10件: Corticotropin; Repository corticotropin injection; H.p. acthar gel (repository corticotropin injection); H.p. acthar® gel (repository corticotropin injection); Corticotropin-releasing hormone; Ovine corticotropin-releasing hormone (ocrh); Corticotropin releasing hormone; Repository corticotropin injection -treatment extension; Adrenocorticotropin; Adrenocorticotropin hormone;   D00146   1件: MC2R   3件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Neuroactive ligand-receptor interaction   12件:
2,
13,
46,
49,
50,
66,
75,
78,
84,
145,
193,
222
 60   Cranberry  1件: Cranberry;   -   -   -   1件:
13
 61   Creatine  4件: Creatine; Creatine monohydrate; Pyruvate, creatine, niacinamide; Creatine-13c;   -   -   -   12件:
1,
2,
5,
6,
8,
13,
46,
49,
50,
113,
156,
201
 62   Curcumin  6件: Curcumin; Ifn beta 1 a + curcumin (bcm 95); Nanocurcumin; Curcumin (longvida™); Curcumin supplement; Bio-enhanced curcumin soft gelatin capsule;   -   -   -   10件:
13,
46,
49,
67,
74,
94,
96,
97,
139,
299
 63   Cyanocobalamin  0件:   D00166
 D03615
 D03616
 D03617 		  -   -   12件:
6,
13,
49,
62,
86,
96,
97,
201,
229,
254,
284,
299
 64   Cyclophosphamide  49件: Cyclophosphamide; Cyclophosphamide (drug); Cyclophosphamide and atg; Cyclophosphamide monohydrate; Cyclophosphamide/glatiramer acetate; Busulfan, cyclophosphamide, antithymocyte globulin; Busulfan, cyclophosphamide, atg; Cyclophosphamide, bortezomib, dexamethasone; Cyclophosphamide, bortezomib, dexamethasone plus daratumumab; Lenalidomide, dexamethasone and cyclophosphamide; Rituximab and cyclophosphamide iv; Prednisone, cyclophosphamide; Cyclophosphamide, azathioprine,prednisone,methylprednisolone; Prednisone, methylprednisolone,cyclophosphamides; Cyclophosphamide-prednisone-azathioprine; Iv cyclophosphamide; Busulfan, fludarabine, & cyclophosphamide with immunosuppression with atg and cyclosporine.; Cyclophosphamide (cy); Cyclophosphamide (cy) (plan 1); Cyclophosphamide (cy) (plan 2); Cyclophosphamide 100mg; Cyclophosphamide 150mg; Cyclophosphamide 50mg; Cyclophosphamide, fludarabine , thymoglobulin; Cyclophosphamide, fludarabine, rabbit atg; Cyclophosphamide, fludarabine, thymoglobulin; Cyclophosphamide,campath ih and tbi; Cyclophosphamide,cyclosporine a; Fludarabine, cyclophosphamide; Haploidentical hsct using tbi free regimen, ''atg'' with ''post transplant cyclophosphamide''; Busulfan, cyclophosphamide, atg, gcsf; Campath, fludarabine, cyclophosphamide; Cyclophosphamide 30; Cyclophosphamide 40; Cyclophosphamide dose level 1; Cyclophosphamide dose level 2; Cyclophosphamide dose level 3; Cyclophosphamide dose level 4; Cyclophosphamide post transplant; Prednisone and cyclophosphamide; Prednisone plus cyclophosphamide; High-dose cyclophosphamide; Cyclophosphamide 50mg oral tablet; Cyclophosphamide and steroids; Cyclophosphamide(ctx); Cyclophosphamide + pred; Cyclophosphamide, fludarabine; Busulfan, cyclophosphamide, thymoglobulin, fludarabine (conditioning regimen); Thalidomide, cyclophosphamide and prednisone;   D00287
 D07760 		  -   -   43件:
13,
14,
16,
19,
20,
26,
28,
35,
36,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
52,
56,
60,
61,
62,
65,
66,
84,
85,
93,
96,
162,
164,
172,
222,
224,
265,
274,
283,
284,
285,
288,
326,
331
 65   Cytarabine  2件: Cytarabine; Carmustine, etoposide, cytarabine, and melphalan (beam);   D00168
 D03046
 D03637 		  -   -   6件:
11,
13,
14,
25,
49,
60
 66   D-Aspartic Acid  0件:   -   -   -   1件:
13
 67   D-glucose  3件: 2-deoxy-2 [f-18] fluoro-2-d-glucose; D-glucose; [18f]fluoro-2-deoxy-2-d-glucose;   D00009   -   -   6件:
6,
13,
49,
86,
88,
299
 68   Daclizumab  7件: Biib019 (daclizumab); Daclizumab; Daclizumab (anti-cd25 humanized monoclonal antibody); Daclizumab high yield process; Daclizumab hyp; Daclizumab hyp (dac hyp); Daclizumab with greek suufix;   D03639   1件: IL2RA   4件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, JAK-STAT signaling pathway   7件:
13,
56,
60,
65,
97,
283,
284
 69   Dalfampridine  5件: Dalfampridine; Dalfampridine er; Dalfampridine-er 10mg; Dalfampridine-er 5mg; Sustained-release oral dalfampridine;   D04127   -   -   3件:
3,
4,
13
 70   Darifenacin  2件: Darifenacin; Oxybutynin and darifenacin;   D01699
 D03654 		  1件: CHRM3   3件: Calcium signaling pathway, Cholinergic synapse, Neuroactive ligand-receptor interaction   2件:
6,
13
 71   Dexamethasone  35件: Dexamethasone; Dexamethasone soduim phosphate; Lenalidomide and dexamethasone; Lenalidomide+dexamethasone; Lenalidomide, dexamethasone; Bortezomib/dexamethasone (bd), followed by autologous stc & maintenance bortezomib/dexamethasone; Cyclophosphamide, bortezomib, dexamethasone; Cyclophosphamide, bortezomib, dexamethasone plus daratumumab; Dexamethasone, 40 mg; Lenalidomide, dexamethasone and cyclophosphamide; Melphalan, thalidomide and dexamethasone; Pomalidomide and dexamethasone; Combination of protein a immunoadsorption, rituximab, dexamethasone plus azathioprine; Dexamethasone (50mg 1dd6, 3 consecutive days/month); Control intervention (no dexamethasone); Intraarticular dexamethasone; Intravenous dexamethasone 1 mg; Peri-neural dexamethasone 1 mg; Dexamethasone parotid irrigation; Dexamethasone (1 cycle); Dexamethasone (4 cycles); Dexamethasone abcur; Dexamethasone and rituximab; High dose dexamethasone pulses; Dexamethasone sodium phosphate; Dexamethasone sodium phosphate ph. eur.; Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone); Dexamethasone 0.5mg tablet; Dexamethasone 2mg tablets; Dexamethasone 0,5mg; Bupivacaine/epinephrine/dexamethasone; Dexamethasone sodium phosphate 250 mg/ 10 ml; Dexamethasone 21-phosphate; Mmf and dexamethasone; Dexamethasone sodium phosphate 250 mg/10 ml solution;   D00292
 D00975
 D01510
 D01615
 D01632
 D01948
 D02174
 D02591
 D02592 		  1件: NR3C1   1件: Neuroactive ligand-receptor interaction   20件:
13,
16,
28,
35,
46,
53,
63,
65,
70,
74,
75,
81,
83,
84,
90,
96,
97,
222,
296,
299
 72   Dexchlorpheniramine  1件: Dexchlorpheniramine;   D07803   1件: HRH1   2件: Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction   1件:
13
 73   Dexrazoxane  2件: Dexrazoxane; Dexrazoxane (drz) plus mitoxantrone (mx);   D03730   -   -   1件:
13
 74   Dextromethorphan  9件: Dextromethorphan; Dextromethorphan hbr and quinidine sulfate; Dextromethorphan hydrobromide 20 mg and quinidine sulfate 10 mg; Dextromethorphan hydrobromide 30 mg and quinidine sulfate 10 mg; Dextromethorphan/quinidine 20mg/10mg (dm/q 20mg/10mg); Dimebon + dextromethorphan; Dextromethorphan hydrobromide; Dextromethorphan and caffeine; Dextromethorphan 30 mg;   D00848
 D03742
 D03744 		  5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   2件: Glutamatergic synapse, Neuroactive ligand-receptor interaction   9件:
2,
6,
8,
13,
46,
78,
96,
97,
156
 75   Diclofenac  9件: Diclofenac; Diclofenac sodium topical gel; Diclofenac sodium; Comparator: diclofenac; Comparator: diclofenac sodium; Diclofenac + omeprazole; Diclofenac natrium pch retard tablet mga 75mg; Diclofenac 50 milligrams; Diclofenac sr;   D00903
 D00904
 D07816 		  2件: PTGS1, PTGS2   1件: Arachidonic acid metabolism   4件:
13,
34,
46,
271
 76   Dimethicone  0件:   D01540   -   -   2件:
13,
96
 77   Dimethyl fumarate  4件: Dimethyl fumarate; Dimethyl fumarate (dmf); Dimethyl fumarate [dmf]; Tecifdera (dimethyl fumarate);   D03846   -   -   5件:
13,
46,
49,
51,
86
 78   Diroximel fumarate  2件: Diroximel fumarate; Diroximel fumarate (drf);   D11154   -   -   1件:
13
 79   Dirucotide  2件: Dirucotide; Dirucotide acetate;   D09396   -   -   1件:
13
 80   Docusate  0件:   D00305   -   -   7件:
13,
62,
86,
96,
97,
254,
284
 81   Domperidone  3件: Domperidone; Domperidone (drug); Levodopa and domperidone;   D01745
 D07868 		  1件: DRD2   2件: Dopaminergic synapse, Neuroactive ligand-receptor interaction   5件:
6,
13,
17,
51,
230
 82   Donepezil  4件: Donepezil; Donepezil sandoz; Donepezil hci (drug); Donepezil hydrochloride;   D00670
 D07869 		  1件: ACHE   2件: Cholinergic synapse, Glycerophospholipid metabolism   9件:
5,
6,
13,
46,
78,
124,
127,
156,
206
 83   Doxycycline  7件: Doxycycline; Interferon beta 1a, oral doxycycline; Doxycycline hyclate; Antimicrobial therapy: co-trimoxazole or doxycycline; Doxycycline 100 mg capsules; Treatment with systemic therapy (doxycycline); Doxycycline hyclate ph.eur;   D00307
 D02129
 D03903
 D03904
 D07876 		  -   -   15件:
13,
23,
28,
46,
84,
85,
89,
96,
97,
158,
162,
167,
227,
280,
299
 84   Dronabinol  4件: Dronabinol; Cannabidiol / dronabinol capsule 5 mg+2,5 mg; Dronabinol capsule 2,5 mg; Dronabinol capsule 2.5. mg;   D00306   2件: CNR1, CNR2   1件: Neuroactive ligand-receptor interaction   5件:
2,
13,
46,
271,
298
 85   Duloxetine  3件: Duloxetine; Duloxetine hydrochloride; Duloxetine hydrochloride (hci);   D01179
 D07880 		  2件: SLC6A2, SLC6A4   2件: Serotonergic synapse, Synaptic vesicle cycle   3件:
6,
13,
49
 86   Dydrogesterone  1件: Dydrogesterone;   D01217   1件: PGR   3件: Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation   1件:
13
 87   Eculizumab  4件: Eculizumab; Abp 959 - biosimilar to eculizumab; Sb12 (proposed eculizumab biosimilar); Soliris (eculizumab);   D03940   1件: C5   1件: Complement and coagulation cascades   7件:
11,
13,
14,
62,
109,
222,
223
 88   Efalizumab  1件: Efalizumab;   D03959   1件: ITGAL   2件: Cell adhesion molecules (CAMs), Natural killer cell mediated cytotoxicity   9件:
11,
13,
37,
46,
49,
53,
61,
95,
96
 89   Elezanumab  1件: Elezanumab;   D11355   1件: RGMA   1件: Axon guidance   1件:
13
 90   Epigallocatechin  5件: Coconut oil and epigallocatechin gallate; Epigallocatechin; Epigallocatechin gallate; Epigallocatechin-3-gallate (egcg); Epigallocatechin-gallate;   -   -   -   4件:
13,
28,
85,
113
 91   Epigallocatechin gallate  2件: Coconut oil and epigallocatechin gallate; Epigallocatechin gallate;   -   -   -   8件:
6,
13,
17,
28,
85,
113,
206,
299
 92   Epinephrine  4件: Epinephrine; Bupivacaine/epinephrine/dexamethasone; Lap tap bupivacaine/epinephrine; Us tap bupivacaine/epinephrine;   D00095
 D00996
 D02149 		  9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3   7件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   9件:
6,
13,
46,
86,
96,
168,
226,
231,
256
 93   Erythropoietin  4件: Erythropoietin; Recombinant human erythropoietin(rhepo); Erythropoietin human recombinant (eporh); Recombinant human erythropoietin;   D03231   1件: EPOR   3件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway   9件:
2,
6,
13,
22,
46,
47,
70,
95,
96
 94   Escitalopram  3件: Escitalopram; Oral escitalopram; Escitalopram oxalate antidepressant;   D02567
 D07704
 D07913 		  1件: SLC6A4   1件: Serotonergic synapse   3件:
2,
6,
13
 95   Estradiol  9件: Estradiol; Estradiol hemihydrate; Ethinylestradiol; Ethinyl estradiol; Loestrin 1.5/30 (1.5 mg norethindrone acetate/30 µg ethinyl estradiol); 5% lidocaine/5 mg/ml estradiol compound cream; Estradiol 2 mg; Loestrin (norethindrone acetate and ethinyl estradiol); Ortho-cyclen, ethinyl estradiol/norgestimate, 0.035 mg/0.250 mg;   D00105
 D01413
 D01617
 D01953
 D04061
 D04063
 D04064
 D04065 		  2件: ESR1, ESR2   2件: Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway   5件:
13,
46,
49,
226,
299
 96   Estriol  2件: Estriol; Vaginal estriol;   D00185
 D01986 		  2件: ESR1, ESR2   2件: Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway   2件:
13,
227
 97   Eszopiclone  1件: Eszopiclone;   D02624   16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   2件: GABAergic synapse, Neuroactive ligand-receptor interaction   3件:
6,
13,
46
 98   Ethanol  14件: Endocannabinoid palmitoylethanolamide (pea); Palmitoylethanolamide; Treprostinil diethanolamine; Ut-15c (treprostinil diethanolamine); Ut-15c sr (treprostinil diethanolamine); Andrographis paniculata (ethanol extract); Ethanol; Ethanol (96 per cent); Ethanol 96% gel; Ethanol 98% solution; Ethanol bp; Ethanol gel; Ethanolamine; Ethanolamine oleate;   D00068
 D02798
 D04855
 D06542 		  -   -   49件:
2,
11,
13,
14,
26,
35,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
58,
61,
63,
64,
65,
66,
81,
84,
85,
86,
88,
95,
96,
97,
113,
145,
162,
164,
222,
224,
228,
251,
279,
280,
283,
284,
285,
288,
298,
299,
300,
331
 99   Ethinylestradiol  1件: Ethinylestradiol;   D00554   1件: ESR1   3件: Breast cancer, Estrogen signaling pathway, Pathways in cancer   4件:
13,
46,
49,
299
 100   Etifoxine  1件: Etifoxine;   D07320   -   -   1件:
13
 101   Etoposide  2件: Etoposide; Carmustine, etoposide, cytarabine, and melphalan (beam);   D00125
 D04107 		  -   -   11件:
11,
13,
14,
26,
28,
34,
60,
65,
85,
164,
331
 102   Evobrutinib  2件: Evobrutinib; M2951 (other name: evobrutinib);   -   -   -   3件:
13,
46,
49
 103   Febuxostat  1件: Febuxostat;   D01206   1件: XDH   2件: Peroxisome, Purine metabolism   3件:
2,
6,
13
 104   Ferric oxide  0件:   D04168   -   -   1件:
13
 105   Ferumoxytol  1件: Ferumoxytol;   D04177   -   -   1件:
13
 106   Filgrastim  7件: Filgrastim; Pegfilgrastim; Ep2006 (filgrastim); Filgrastim hexal; Filgrastim, alemtuzumab; Granulocyte colony-stimulating factor (filgrastim); Filgrastim (g-csf);   D03235   1件: CSF3R   5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   28件:
2,
6,
13,
16,
25,
26,
28,
34,
35,
36,
40,
41,
42,
45,
46,
49,
51,
60,
62,
65,
85,
96,
113,
164,
283,
284,
285,
331
 107   Fingolimod  7件: 0,5 mg fingolimod; Fingolimod; Fingolimod (fty720); Fingolimod 0.5 mg; Fingolimod 1.25 mg; Fingolimod hydrochloride; Fingolimodi;   D10001   1件: S1PR1   2件: Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway   4件:
2,
13,
14,
156
 108   Firategrast  7件: Firategrast; Firategrast (usan approved name); Firategrast 150 mg; Firategrast 300 mg; Firategrast gastro-retentive solution; Firategrast immediate release tablet; Firategrast modified release tablet;   D06590   1件: ITGA4   3件: Cell adhesion molecules (CAMs), ECM-receptor interaction, Focal adhesion   1件:
13
 109   Fish oil  10件: Fish oil; Fish oil concentrate; Fish oil, rich in omega-3-acids; Fish oil,rich in omega 3 acids; Lipoic acid (la) with fish oil and la without fish oil; Combination fish oil and borage seed oil; Fish oil supplement; Fish oil, gamma-linolenic acid; Omega-3 fatty acid fish oil supplement; Combination of fish oil and colesevelam;   -   -   -   7件:
13,
46,
49,
66,
96,
260,
299
 110   Fludarabine  23件: Fludarabine; Fludarabine phosphate; Fludarabine monophosphate; Sq fludarabine; Busulfan, fludarabine, & cyclophosphamide with immunosuppression with atg and cyclosporine.; Busulfan/fludarabine phosphate/tacrolimus/methotrexate/g-csf; Cyclophosphamide, fludarabine , thymoglobulin; Cyclophosphamide, fludarabine, rabbit atg; Cyclophosphamide, fludarabine, thymoglobulin; Fludarabine (flu); Fludarabine, cyclophosphamide; Fludarabine/ melphalan; Fludarabine/busulfan; Busulfan, fludarabine and atg; Busulfan, fludarabine, atg, tli; Campath, fludarabine, cyclophosphamide; Fludarabine phosphate 30 mg; Fludarabine phosphate 40 mg; Fludarabine, busulfan, thymoglobulin; Fludarabine, melphalan, thiotepa; Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan; Cyclophosphamide, fludarabine; Busulfan, cyclophosphamide, thymoglobulin, fludarabine (conditioning regimen);   D01907
 D07966 		  1件: RRM1   2件: Purine metabolism, Pyrimidine metabolism   17件:
13,
28,
36,
46,
49,
51,
60,
61,
62,
65,
85,
96,
164,
283,
284,
285,
326
 111   Fludeoxyglucose F-18  0件:   -   -   -   8件:
6,
13,
34,
46,
53,
84,
127,
300
 112   Flumazenil  4件: Flumazenil; Pet with 11c-flumazenil; [11c]flumazenil; 11c-flumazenil;   D00697   16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   2件: GABAergic synapse, Neuroactive ligand-receptor interaction   5件:
6,
13,
17,
18,
206
 113   Fluoxetine  4件: Fluoxetine; Fluoxetine hydrochloride; Amitriptyline, fluoxetine and tramadol alone (control group); Sc recombinant growth hormone + amitriptyline, fluoxetine and tramadol (treated group);   D00326
 D00823 		  1件: SLC6A4   1件: Serotonergic synapse   6件:
13,
17,
78,
86,
179,
206
 114   Flupirtine  1件: Flupirtine;   D07978   -   -   1件:
13
 115   Flurbiprofen  3件: Flurbiprofen; Bms drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin); Montelukast, flurbiprofen, midazolam, digoxin, pravastatin and bms-986142;   D00330
 D01475
 D02290 		  2件: PTGS1, PTGS2   2件: Arachidonic acid metabolism, Serotonergic synapse   2件:
13,
46
 116   Folic acid  5件: Folic acid; Folic acid, vitamin b6, vitamin b12; Folic acid or folate; Rituximab, mtx, folic acid; Methotrexate and folic acid;   D00070   -   -   11件:
6,
13,
46,
49,
62,
84,
86,
96,
97,
254,
284
 117   Fumaric Acid  2件: Fumaric acid; Second-generation fumaric acid;   D02308   -   -   1件:
13
 118   GSK-2018682  0件:   -   -   -   1件:
13
 119   GSK-239512  0件:   -   -   -   1件:
13
 120   Gabapentin  7件: Gabapentin; Gabapentina; Gabapentina kern pharma; Gabapentine; Gabapentine 300mg; Transdermal fentanyl matrix, gabapentin; Gabapentin prescriptions;   D00332   5件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1   2件: GABAergic synapse, MAPK signaling pathway   7件:
6,
13,
19,
70,
97,
226,
298
 121   Gadobenic acid  0件:   D04283
 D08018 		  -   -   3件:
13,
86,
88
 122   Gadobutrol  1件: Gadobutrol;   D07420   -   -   3件:
13,
22,
46
 123   Gadolinium  6件: Gadolinium; Gadolinium-based contrast; Standard gadolinium contrast; Gadolinium contrast; Gadolinium for abdomen; Gadolinium for lower back;   -   -   -   6件:
13,
34,
46,
58,
65,
305
 124   Gadoteric acid  1件: Gadoteric acid;   D08007   -   -   2件:
13,
53
 125   Gadoteridol  2件: Gadoteridol; Prohance (gadoteridol);   D01137   -   -   1件:
13
 126   Ginkgo biloba  2件: Ginkgo biloba; Ginkgo biloba pills sig: 300mg/tid;   -   -   -   3件:
6,
13,
90
 127   Ginseng  4件: American ginseng; American ginseng extract ht-1001; Ginseng; Korean red ginseng;   D06772   -   -   3件:
13,
46,
53
 128   Glatiramer  23件: 40 mg glatiramer acetate; Glatiramer; 20mg/0.5ml glatiramer acetate; Cyclophosphamide/glatiramer acetate; Experimental glatiramer acetate; Glatiramer acetate; Glatiramer acetate (db); Glatiramer acetate (ga); Glatiramer acetate (ga) 40 mg; Glatiramer acetate (ol); Glatiramer acetate 150mg enteric coated tablets; Glatiramer acetate 150mg enteric-coated (gastro-resistant) tablets; Glatiramer acetate 20 mg; Glatiramer acetate 20 mg, with mitoxantrone; Glatiramer acetate 20 mg/0.5 ml; Glatiramer acetate 40 mg; Glatiramer acetate injection with oral cetirizine hydrochloride; Glatiramer acetate with minocycline; Glatiramer acetate, (copaxone®); Glatiramer acetate, ifn-beta 1a (im), ifn-beta 1a (subcutaneous), and ifn-beta 1b; Glatiramer acetate, n-acetylcysteine; Human interferon beta-1a and glatiramer acetate; Glatiramer acetate (copaxone®);   D04318   20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G   1件: Antigen processing and presentation   4件:
2,
13,
96,
156
 129   Glutamic Acid  0件:   D00007
 D04341 		  -   -   1件:
13
 130   Glycerin  1件: Glycerine;   D00028   -   -   6件:
6,
13,
53,
265,
316,
317
 131   Gold  3件: Gold; Gold nanocrystals; Sodium aurothiomalate (intramuscular gold);   -   -   -   5件:
2,
6,
13,
46,
171
 132   Green olive  0件:   -   -   -   3件:
13,
49,
53
 133   Guanabenz  2件: Guanabenz; Guanabenz acetato;   D04375   3件: ADRA2A, ADRA2B, ADRA2C   1件: Neuroactive ligand-receptor interaction   2件:
2,
13
 134   Histidine  3件: Histidine; L-histidine; Copper histidine;   D00032   -   -   3件:
13,
169,
170
 135   Human interferon beta  6件: Human interferon beta; Human interferon beta 1a (rebif); Human interferon beta-1a and glatiramer acetate; New formulation of rebif - human interferon beta-1a; Recombinant human interferon beta; Recombinant human interferon beta-1a;   -   -   -   6件:
13,
14,
20,
26,
96,
97
 136   Human interleukin-2  3件: Human interleukin-2; Recombinant human interleukin-2 (rhil-2); Anti-human interleukin-23 monoclonal antibody;   -   -   -   14件:
2,
13,
35,
46,
49,
51,
55,
56,
63,
65,
95,
96,
97,
271
 137   Hydrochlorothiazide  2件: Hydrochlorothiazide; Hydrochlorothiazide/amiloride;   D00340   -   -   3件:
13,
67,
225
 138   Hydroxychloroquine  16件: Hydroxychloroquine; Hydroxychloroquine sulfate; Leflunomide-sulfasalazine-hydroxychloroquine; Methotrexate + salazopyrine + hydroxychloroquine administration; Methotrexate-sulfasalazine-hydroxychloroquine; Sulphasalazine + hydroxychloroquine or prednisolone; Hydroxychloroquine (z0188); Hydroxychloroquine high; Hydroxychloroquine or chloroquine; Hydroxychloroquine reduced; Versus hydroxychloroquine; Hydroxychloroquine + prednisone; Sirolimus and hydroxychloroquine; Hydroxychloroquine higher dose; Hydroxychloroquine lower dose; Hydroxychloroquine sulphate;   D08050   -   -   18件:
13,
41,
46,
48,
49,
53,
56,
66,
84,
89,
90,
96,
222,
234,
254,
271,
298,
299
 139   Hydroxytyrosol  2件: Essential - hydroxytyrosol; Hydroxytyrosol;   -   -   -   1件:
13
 140   Hydroxyurea  1件: Hydroxyurea;   D00341   1件: RRM2   4件: Glutathione metabolism, Purine metabolism, Pyrimidine metabolism, p53 signaling pathway   8件:
3,
13,
19,
20,
65,
85,
86,
284
 141   Ibudilast  1件: Ibudilast;   D01385   8件: CYSLTR1, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PTGIR   4件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   2件:
2,
13
 142   Ibuprofen  5件: Ibuprofen; Rebif new formulation + ibuprofen prn; Rebif new formulation + prophylactic ibuprofen; Ibuprofen pch tablet 600mg; Ibuprofen 200mg;   D00126
 D01122
 D04490
 D06606 		  2件: PTGS1, PTGS2   1件: Arachidonic acid metabolism   6件:
13,
46,
65,
113,
271,
299
 143   Idebenone  2件: Idebenone; Idebenone 150 mg film-coated tablets;   D01750   -   -   4件:
6,
13,
113,
302
 144   Imatinib  6件: Imatinib; Imatinib mesilate; Imatinib mesylate; Imatinib mesylate (gleevec); Bevacizumab (avastin) and imatinib mesylate (gleevec); Imatinib mesylate 400mg capsule;   D01441
 D08066 		  3件: ABL1, KIT, PDGFRA   3件: Chronic myeloid leukemia, MAPK signaling pathway, Pathways in cancer   11件:
13,
28,
34,
35,
46,
51,
85,
86,
87,
89,
162
 145   Immune Globulin Human  0件:   -   -   -   20件:
2,
11,
13,
14,
17,
18,
35,
38,
39,
43,
45,
49,
50,
51,
63,
65,
85,
164,
296,
309
 146   Indian frankincense  0件:   -   -   -   1件:
13
 147   Inosine  2件: Inosine; 1) inosine 5'-monophosphate;   D00054   -   -   4件:
2,
6,
13,
17
 148   Interferon beta-1a  24件: Avonex (interferon beta-1a), biogen idec ltd; Bg9418 (interferon beta-1a); Biib017 (peginterferon beta-1a); Human interferon beta-1a and glatiramer acetate; Interferon beta-1a; Interferon beta-1a (avonex); Interferon beta-1a (avonex®); Interferon beta-1a (current approved manufacturing process invloving fbs); Interferon beta-1a (new process, manufactured without fbs); Interferon beta-1a (rebif); Interferon beta-1a 30 µg; Interferon beta-1a fbs-free/hsa-free, rnf; Interferon beta-1a hsa+ biosimilar; Interferon beta-1a hsa-free biosimilar; Interferon beta-1a original; New formulation of rebif - human interferon beta-1a; Peginterferon beta-1a; Pegylated interferon beta-1a; Plegridy (peginterferon beta-1a), biogen idec ltd; Rebif (interferon beta-1a); Rebif (interferon beta-1a), merck serono europe ltd; Sc interferon beta-1a; Sc peginterferon beta-1a; Recombinant human interferon beta-1a;   D04554   2件: IFNAR1, IFNAR2   4件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Natural killer cell mediated cytotoxicity, Toll-like receptor signaling pathway   5件:
13,
14,
26,
96,
97
 149   Interferon beta-1b  19件: Betaferon® (interferon beta-1b); Betaseron (interferon beta-1b, bay86-5046); Betaseron (interferon beta-1b, bay86-5046), bayer healthcare ag; Extavia (interferon beta-1b), novartis pharma ag; Interferon beta-1b; Interferon beta-1b (betaferon, bay 86-5046); Interferon beta-1b (betaferon, bay86-5046); Interferon beta-1b (betaferon/betaseron, bay86-5046); Interferon beta-1b (betaferon®, bay 86-5046); Interferon beta-1b (betaseron, bay86-5046); Interferon beta-1b (betaseron, betaferon, bay86-5046); Interferon beta-1b (pf530, betaferon); Interferon beta-1b and tacrolimus; Interferon beta-1b group; Interferon beta-1b, (betaseron bay86-5046); Interferon beta-1b/atorvastatin group; Msdmds other than betaseron (interferon beta-1b, bay86-5046); Recombinant interferon beta-1b; Sc interferon beta-1b;   D00746   2件: IFNAR1, IFNAR2   4件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Natural killer cell mediated cytotoxicity, Toll-like receptor signaling pathway   1件:
13
 150   Iron  18件: Iron; Iron oxide; Ultra small particles of iron oxide (uspio); Ultrasmall particles of iron oxide; Iron dextran; Iron sucrose; Ambrisentan plus spironolactone; Iron supplement; Spironolactone; Spironolactone and conivaptan; Spironolactone captopril carvedilol; Injection of iron; Iron sulphate; Iron sulphate 200mg coated tablets; Iron supplement 300-600 mg/day; Iron(iii)- hydroxide dextran complex; Oral iron; Iron chelating agents;   -   -   -   7件:
13,
62,
86,
96,
97,
254,
284
 151   Isopropyl alcohol  0件:   D00137   -   -   10件:
13,
46,
58,
84,
96,
97,
269,
271,
279,
298
 152   Isoxaflutole  0件:   -   -   -   8件:
5,
6,
13,
18,
81,
113,
149,
299
 153   Isoxsuprine  2件: Isoxsuprine; Isoxsuprine hydrochloride;   D08092   1件: ADRB2   2件: Adrenergic signaling in cardiomyocytes, Neuroactive ligand-receptor interaction   1件:
13
 154   Ixazomib  3件: Ixazomib; Ixazomib (ninlaro®) capsules; Ixazomib citrate;   D10130   1件: PSMB5   1件: Proteasome   4件:
13,
16,
28,
61
 155   Ketamine  5件: Ketamine; Esketamine; Esketamine hydrochloride; S-ketamine; S-ketamine & midazolam;   D00711
 D08098 		  5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   3件: Calcium signaling pathway, Glutamatergic synapse, Neuroactive ligand-receptor interaction   6件:
6,
13,
70,
113,
156,
215
 156   Ketoconazole  3件: Dimebon + ketoconazole; Ketoconazole; Levoketoconazole;   D00351   1件: CYP17A1   1件: Steroid hormone biosynthesis   3件:
8,
13,
75
 157   L-Alanine  1件: L-alanine;   D00012   -   -   3件:
13,
298,
299
 158   L-Cysteine  1件: N-acetyl-cysteine;   D00026
 D02326 		  -   -   9件:
6,
13,
19,
84,
85,
88,
90,
254,
296
 159   L-Lysine  2件: L-lysine; L-lysine-n-acetylcysteinate;   D02304   -   -   4件:
13,
97,
228,
299
 160   Lactose  4件: Lactose; Lactose monohydrate; 2'-fucosyllactose; Lactose in water;   D00046
 D03226 		  -   -   6件:
2,
6,
13,
97,
228,
310
 161   Lamotrigine  3件: Lamotrigine; Lamotrigine extended release tablets; Lamotrigine dispers;   D00354   1件: SCN1A   1件: Dopaminergic synapse   3件:
13,
34,
114
 162   Laquinimod  8件: Laquinimod; Laquinimod 0.6; Laquinimod 1.2; Laquinimod capsules 0.3 mg; Laquinimod capsules 0.6 mg; Laquinimod sodium (usan); Laquinimod tablets 0.3 mg; Laquinimod cápsulas 0.5 mg;   -   -   -   4件:
8,
13,
49,
96
 163   Levetiracetam  1件: Levetiracetam;   D00709   1件: SV2A   1件: ECM-receptor interaction   4件:
2,
4,
6,
13
 164   Levocarnitine  4件: Levocarnitine; Valproate, levocarnitine; Valproic acid and levocarnitine; Levocarnitine propyl hydrochloride;   D02030
 D02176
 D04713 		  -   -   10件:
3,
5,
13,
53,
58,
96,
97,
265,
298,
316
 165   Levoleucovorin  0件:   D04715   -   -   1件:
13
 166   Levonorgestrel  1件: Levonorgestrel;   D00950   1件: PGR   3件: Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation   1件:
13
 167   Lidocaine  8件: Lidocaine; Local anesthesia (lidocaine hydrochloride); Lidocaine patch 5%; Lidocaine injection 2%; 5% lidocaine/5 mg/ml estradiol compound cream; Alkalinized lidocaine-heparin; Bladder instillation with heparin/ lidocaine; Lidocaine releasing intravesical system - liris®;   D00358
 D02086
 D08127 		  2件: SCN1A, SCN5A   2件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse   10件:
6,
13,
46,
84,
86,
97,
168,
226,
231,
256
 168   Linoleic acid  2件: Linoleic acid; Linoleic acid/oleic acid;   -   -   -   1件:
13
 169   Liothyronine  3件: Liothyronine; Liothyronine sodium; Liothyronine i 131;   D01011
 D08128 		  2件: THRA, THRB   2件: Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway   3件:
13,
78,
212
 170   Lipoic Acid  8件: Alpha-lipoic acid; Lipoic acid; Alpha-lipoic acid and l-acetyl carnitine; Alpha lipoic acid; Lipoic acid (la) with fish oil and la without fish oil; Lipoic acid and omega-3 fatty acids; Oral lipoic acid (la); R lipoic acid;   D00048
 D00086 		  -   -   5件:
2,
5,
13,
14,
20
 171   Lisdexamfetamine  2件: Lisdexamfetamine; Lisdexamfetamine sulfate;   D08130   2件: SLC6A2, SLC6A3   2件: Dopaminergic synapse, Synaptic vesicle cycle   1件:
13
 172   Lithium carbonate  1件: Lithium carbonate;   D00801   -   -   8件:
2,
5,
7,
8,
13,
17,
19,
127
 173   Loperamide  1件: Loperamide;   D00729